Publication | Open Access
Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double‐blind trial
100
Citations
13
References
2010
Year
In Japanese patients with type 2 diabetes, once-daily sitagliptin monotherapy showed greater efficacy and better tolerability than thrice-daily voglibose over 12 weeks.
| Year | Citations | |
|---|---|---|
Page 1
Page 1